- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
| 營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24Q4 (20) | 1.51 | 65.93 | 96.1 | 0.07 | -12.5 | 0.0 | 0.11 | -21.43 | -15.38 | 0.19 | 5.56 | 11.76 | 4.64 | -47.27 | -49.01 | 7.28 | -52.65 | -56.85 | 12.58 | -36.39 | -43.01 | 170 | 0.0 | 0.0 |
| 24Q3 (19) | 0.91 | -30.53 | 24.66 | 0.08 | 0.0 | 14.29 | 0.14 | 7.69 | 16.67 | 0.18 | 12.5 | 38.46 | 8.79 | 43.96 | -8.32 | 15.38 | 55.03 | -6.41 | 19.78 | 61.95 | 11.07 | 170 | 0.0 | -10.99 |
| 24Q2 (18) | 1.31 | 61.73 | -17.09 | 0.08 | 33.33 | 0.0 | 0.13 | 18.18 | -13.33 | 0.16 | 0.0 | 23.08 | 6.11 | -17.56 | 20.61 | 9.92 | -26.93 | 4.53 | 12.21 | -38.17 | 48.44 | 170 | 0.0 | -10.99 |
| 24Q1 (17) | 0.81 | 5.19 | 1.25 | 0.06 | -14.29 | 0.0 | 0.11 | -15.38 | -21.43 | 0.16 | -5.88 | 33.33 | 7.41 | -18.52 | -1.23 | 13.58 | -19.56 | -22.4 | 19.75 | -10.53 | 31.69 | 170 | 0.0 | -10.99 |
| 23Q4 (16) | 0.77 | 5.48 | -4.94 | 0.07 | 0.0 | 0.0 | 0.13 | 8.33 | -18.75 | 0.17 | 30.77 | 6.25 | 9.09 | -5.19 | 5.19 | 16.88 | 2.71 | -14.53 | 22.08 | 23.98 | 11.77 | 170 | -10.99 | -10.99 |
| 23Q3 (15) | 0.73 | -53.8 | -56.55 | 0.07 | -12.5 | -12.5 | 0.12 | -20.0 | -25.0 | 0.13 | 0.0 | -13.33 | 9.59 | 89.38 | 101.37 | 16.44 | 73.15 | 72.6 | 17.81 | 116.44 | 99.45 | 191 | 0.0 | -8.61 |
| 23Q2 (14) | 1.58 | 97.5 | 22.48 | 0.08 | 33.33 | 0.0 | 0.15 | 7.14 | -16.67 | 0.13 | 8.33 | -13.33 | 5.06 | -32.49 | -18.35 | 9.49 | -45.75 | -31.96 | 8.23 | -45.15 | -29.24 | 191 | 0.0 | -8.61 |
| 23Q1 (13) | 0.8 | -1.23 | -53.76 | 0.06 | -14.29 | -25.0 | 0.14 | -12.5 | -6.67 | 0.12 | -25.0 | 9.09 | 7.50 | -13.21 | 62.19 | 17.50 | -11.41 | 101.83 | 15.00 | -24.06 | 135.91 | 191 | 0.0 | -8.61 |
| 22Q4 (12) | 0.81 | -51.79 | -67.34 | 0.07 | -12.5 | -12.5 | 0.16 | 0.0 | -5.88 | 0.16 | 6.67 | 23.08 | 8.64 | 81.48 | 167.9 | 19.75 | 107.41 | 188.16 | 19.75 | 121.23 | 276.83 | 191 | -8.61 | -8.61 |
| 22Q3 (11) | 1.68 | 30.23 | -54.72 | 0.08 | 0.0 | -20.0 | 0.16 | -11.11 | -20.0 | 0.15 | 0.0 | 25.0 | 4.76 | -23.21 | 76.67 | 9.52 | -31.75 | 76.67 | 8.93 | -23.21 | 176.04 | 209 | 0.0 | -46.55 |
| 22Q2 (10) | 1.29 | -25.43 | -58.65 | 0.08 | 0.0 | -27.27 | 0.18 | 20.0 | 0.0 | 0.15 | 36.36 | 25.0 | 6.20 | 34.11 | 75.9 | 13.95 | 60.93 | 141.86 | 11.63 | 82.88 | 202.33 | 209 | 0.0 | -46.55 |
| 22Q1 (9) | 1.73 | -30.24 | -42.33 | 0.08 | 0.0 | -20.0 | 0.15 | -11.76 | -34.78 | 0.11 | -15.38 | -15.38 | 4.62 | 43.35 | 38.73 | 8.67 | 26.49 | 13.09 | 6.36 | 21.3 | 46.73 | 209 | 0.0 | -46.55 |
| 21Q4 (8) | 2.48 | -33.15 | -14.19 | 0.08 | -20.0 | 60.0 | 0.17 | -15.0 | 13.33 | 0.13 | 8.33 | 0.0 | 3.23 | 19.68 | 86.45 | 6.85 | 27.16 | 32.07 | 5.24 | 62.06 | 16.53 | 209 | -46.55 | -46.55 |
| 21Q3 (7) | 3.71 | 18.91 | 18.53 | 0.1 | -9.09 | -16.67 | 0.2 | 11.11 | 33.33 | 0.12 | 0.0 | -7.69 | 2.70 | -23.55 | -29.69 | 5.39 | -6.56 | 12.49 | 3.23 | -15.9 | -22.12 | 391 | 0.0 | 92.61 |
| 21Q2 (6) | 3.12 | 4.0 | 47.17 | 0.11 | 10.0 | -21.43 | 0.18 | -21.74 | -33.33 | 0.12 | -7.69 | -50.0 | 3.53 | 5.77 | -46.61 | 5.77 | -24.75 | -54.7 | 3.85 | -11.24 | -66.03 | 391 | 0.0 | 92.61 |
| 21Q1 (5) | 3.0 | 3.81 | 0 | 0.1 | 100.0 | 0 | 0.23 | 53.33 | 0 | 0.13 | 0.0 | 0 | 3.33 | 92.67 | 0 | 7.67 | 47.71 | 0 | 4.33 | -3.67 | 0 | 391 | 0.0 | 0 |
| 20Q4 (4) | 2.89 | -7.67 | 0.0 | 0.05 | -58.33 | 0.0 | 0.15 | 0.0 | 0.0 | 0.13 | 0.0 | 0.0 | 1.73 | -54.87 | 0.0 | 5.19 | 8.3 | 0.0 | 4.50 | 8.3 | 0.0 | 391 | 92.61 | 0.0 |
| 20Q3 (3) | 3.13 | 47.64 | 0.0 | 0.12 | -14.29 | 0.0 | 0.15 | -44.44 | 0.0 | 0.13 | -45.83 | 0.0 | 3.83 | -41.94 | 0.0 | 4.79 | -62.37 | 0.0 | 4.15 | -63.31 | 0.0 | 203 | 0.0 | 0.0 |
| 20Q2 (2) | 2.12 | 0 | 0.0 | 0.14 | 0 | 0.0 | 0.27 | 0 | 0.0 | 0.24 | 0 | 0.0 | 6.60 | 0 | 0.0 | 12.74 | 0 | 0.0 | 11.32 | 0 | 0.0 | 203 | 0 | 0.0 |
| 營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 (10) | 4.54 | 17.31 | 0.3 | 7.14 | 0.5 | -7.41 | 0.69 | 27.78 | 6.61 | -8.67 | 11.01 | -21.07 | 15.20 | 8.92 | 170 | 0.0 |
| 2023 (9) | 3.87 | -29.89 | 0.28 | -12.5 | 0.54 | -16.92 | 0.54 | -5.26 | 7.24 | 24.81 | 13.95 | 18.5 | 13.95 | 35.13 | 170 | -10.99 |
| 2022 (8) | 5.52 | -55.16 | 0.32 | -15.79 | 0.65 | -15.58 | 0.57 | 14.0 | 5.80 | 87.8 | 11.78 | 88.25 | 10.33 | 154.23 | 191 | -8.61 |
| 2021 (7) | 12.31 | 51.41 | 0.38 | 26.67 | 0.77 | 35.09 | 0.5 | 2.04 | 3.09 | -16.34 | 6.26 | -10.78 | 4.06 | -32.61 | 209 | -46.55 |
| 2020 (6) | 8.13 | 53.98 | 0.3 | 3.45 | 0.57 | 3.64 | 0.49 | -7.55 | 3.69 | -32.82 | 7.01 | -32.69 | 6.03 | -39.96 | 391 | 92.61 |
| 2019 (5) | 5.28 | -21.08 | 0.29 | 7.41 | 0.55 | 34.15 | 0.53 | 20.45 | 5.49 | 36.09 | 10.42 | 69.97 | 10.04 | 52.62 | 203 | -10.57 |
| 2018 (4) | 6.69 | 18.62 | 0.27 | -10.0 | 0.41 | 13.89 | 0.44 | -13.73 | 4.04 | -24.13 | 6.13 | -3.99 | 6.58 | -27.27 | 227 | -4.62 |
| 2017 (3) | 5.64 | -41.86 | 0.3 | -23.08 | 0.36 | -65.71 | 0.51 | -7.27 | 5.32 | 32.3 | 6.38 | -41.03 | 9.04 | 59.48 | 238 | -26.77 |
| 2016 (2) | 9.7 | -6.19 | 0.39 | -7.14 | 1.05 | 43.84 | 0.55 | -24.66 | 4.02 | -1.02 | 10.82 | 53.33 | 5.67 | -19.69 | 325 | -26.8 |
| 2015 (1) | 10.34 | 0.49 | 0.42 | 23.53 | 0.73 | 28.07 | 0.73 | -1.35 | 4.06 | 0 | 7.06 | 0 | 7.06 | 0 | 444 | 825.0 |
